Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myelodysplastic Syndromes 14Leukemia, Myeloid, Acute 13Multiple Myeloma 12Leukemia 12Lymphoma 11Hodgkin Disease 10Hematologic Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Graft vs Host Disease 8Leukemia, Myeloid, Accelerated Phase 7Blast Crisis 7Lymphoma, Non-Hodgkin 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Myeloproliferative Disorders 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasms, Plasma Cell 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelomonocytic, Chronic 3Congenital Abnormalities 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Recurrence 2Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myelodysplastic-Myeloproliferative Diseases 2Mycosis Fungoides 2

Interventions

fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Mycophenolic Acid 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1CT-P10 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Hematopoietic and Lymphoid System Neoplasm × Tacrolimus × Clear all
NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
25 enrolled

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡